QKL Stores Inc. 

(Public, NASDAQ:QKLS)   Watch this stock   
Find more results for QKLS

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 3.99% 5.57%
Operating margin 5.38% 7.76%
EBITD margin - 8.84%
Return on average assets 10.86% 16.02%
Return on average equity 18.12% 29.23%
Employees 3,500 -

Address

Jing Qi Street Dongfeng Xincun Sa er Tu District
Daqing, 163311
China
+86-459-4607825 (Phone)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

QKL Stores Inc. discussed on blogs

Ranking U.S.-Listed Chinese Stocks by Short Interest Monthly ... - Investor's Resources - China Analyst - News and Research on US-Listed Chinese Stocks - 3 hours ago
BEST-Rated U.S.-Listed International Stocks by as of 1/27/2010 ... - Investor's Resources - China Analyst - News and Research on US-Listed Chinese Stocks - Jan 28, 2010

QKL Stores Inc. discussions

  View all discussions »

Description

QKL Stores Inc., formerly Forme Capital, Inc., is the holding company of Daqing Qing Ke Long Chain Commerce & Trade Co., Ltd. (QKL-China). QKL-China is a regional supermarket chain that operated 30 supermarkets and two department stores in northeastern China’s Heilongjiang Province and Inner Mongolia as of July 22, 2009. QKL-China’s supermarkets sell a range of merchandise including groceries, fresh food and non-food items. QKL-China has one distribution center servicing its supermarkets.

Officers and directors

Zhuangyi Wang
Chief Executive Officer, Director
Age: 49
Bio & Compensation - Reuters
Crystal Chen CPA
Chief Financial Officer
Age: 35
Bio & Compensation - Reuters
Alan D. Stewart
Chief Operating Officer, Director
Age: 65
Bio & Compensation - Reuters
Wenbin Teng
Chief Information Officer
Age: 40
Bio & Compensation - Reuters
Xishuang Fan
Assistant Chief Financial Officer
Age: 46
Bio & Compensation - Reuters
Gary B. Crook
Independent Director
Age: 55
Bio & Compensation - Reuters
Chaoying Li
Independent Director
Bio & Compensation - Reuters
Zhiguo Jin
Independent Director
Bio & Compensation - Reuters